{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T03:15:21Z","timestamp":1777000521798,"version":"3.51.4"},"reference-count":35,"publisher":"The Pediatric Pharmacy Association","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"abstract":"<jats:p>Oral mucositis affects more than three-fourths of patients undergoing chemotherapy and represents a significant burden to patients and caregivers. Lesions develop as a result of chemotherapeutic agents attacking the rapidly dividing cells of the gastrointestinal tract. Severity can range from mild, painless tissue changes to bleeding ulcerations that prevent oral intake and require narcotic pain relievers. Oral mucositis also leads to an increased risk of infection and can often delay further chemotherapy treatment. A number of assessment scales have been developed to better qualify the symptoms associated with this condition. Few pharmacologic agents have been approved to either prevent the development or alleviate the symptoms of oral mucositis. Current options include the use of antimicrobial mouthwashes, amino acid rinses, and topical healing agents. Palifermin, a keratinocyte growth factor, may be a future option after its use in children is explored. With achievements in other areas of supportive care in patients undergoing chemotherapy, oral mucositis should represent the forefront of new research. This review will provide a comprehensive examination of available options for children who have oral mucositis.<\/jats:p>","DOI":"10.5863\/1551-6776-17.4.340","type":"journal-article","created":{"date-parts":[[2013,2,6]],"date-time":"2013-02-06T22:00:56Z","timestamp":1360188056000},"page":"340-350","source":"Crossref","is-referenced-by-count":40,"title":["Prevention and Treatment of Oral Mucositis in Children with Cancer"],"prefix":"10.5863","volume":"17","author":[{"given":"Misty M.","family":"Miller","sequence":"first","affiliation":[{"name":"Department of Clinical and Administrative Sciences, University of Oklahoma College of Pharmacy, Oklahoma City, Oklahoma"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David V.","family":"Donald","sequence":"additional","affiliation":[{"name":"The Children's Hospital at Saint Francis, Tulsa, Oklahoma"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy M.","family":"Hagemann","sequence":"additional","affiliation":[{"name":"Department of Clinical and Administrative Sciences, University of Oklahoma College of Pharmacy, Oklahoma City, Oklahoma"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3883","reference":[{"issue":"6 suppl 3","key":"i1551-6776-17-4-340-b1","series-title":"J Support Oncol","first-page":"3","article-title":"Oral mucositis in cancer therapy","volume":"2","year":"2004","unstructured":"Sonis\n              ST.\n            \n          \n          Oral mucositis in cancer therapy. J Support Oncol. 2004;2(6 suppl 3):3\u20138."},{"issue":"8","key":"i1551-6776-17-4-340-b2","series-title":"Eur J Cancer","first-page":"1208","article-title":"Prevention of oral mucositis in paediatric patients treated with chemotherapy; a randomised crossover trial comparing two protocols of oral care","volume":"40","year":"2004","unstructured":"Cheng\n              KK\n            , ChangAM, YuenMP.\n          Prevention of oral mucositis in paediatric patients treated with chemotherapy; a randomised crossover trial comparing two protocols of oral care. Eur J Cancer. 2004;40(8):1208\u20131216."},{"issue":"3","key":"i1551-6776-17-4-340-b3","series-title":"Int J Paediatr Dent","first-page":"210","article-title":"Determinants of severe oral mucositis in paediatric cancer patients: a prospective study","volume":"21","year":"2011","unstructured":"Otmani\n              N\n            , AlamiR, HessissenL, \n          et al. Determinants of severe oral mucositis in paediatric cancer patients: a prospective study. Int J Paediatr Dent. 2011;21(3):210\u2013216."},{"issue":"11","key":"i1551-6776-17-4-340-b4","series-title":"J Clin Nurs","first-page":"2114","article-title":"Oral mucositis, dysfunction, and distress in patients undergoing cancer therapy","volume":"16","year":"2007","unstructured":"Cheng\n              KK.\n            \n          \n          Oral mucositis, dysfunction, and distress in patients undergoing cancer therapy. J Clin Nurs. 2007;16(11):2114\u20132121."},{"issue":"3","key":"i1551-6776-17-4-340-b5","series-title":"J Pediatr Oncol Nurs","first-page":"164","article-title":"Assessment and management of chemotherapy-induced mucositis in children","volume":"14","year":"1997","unstructured":"Kennedy\n              L\n            , DiamondJ.\n          Assessment and management of chemotherapy-induced mucositis in children. J Pediatr Oncol Nurs. 1997;14(3):164\u2013174."},{"issue":"6","key":"i1551-6776-17-4-340-b6","series-title":"Curr Hematol Rep","first-page":"446","article-title":"Mucosal protection by cytokines","volume":"4","year":"2005","unstructured":"Hofmeister\n              CC\n            , StiffPJ.\n          Mucosal protection by cytokines. Curr Hematol Rep. 2005;4(6):446\u2013453."},{"key":"i1551-6776-17-4-340-b7","series-title":"Pharmacotherapy: A Pathophysiologic Approach","article-title":"Cancer treatment and chemotherapy","year":"2011","unstructured":"Medina\n              PJ\n            , ShordSS.\n          Cancer treatment and chemotherapy. In: TalbertRL, DiPiroJT, MatzkeGR, et al, eds. Pharmacotherapy: A Pathophysiologic Approach. 8th ed. New York: McGraw-Hill; 2011."},{"issue":"16","key":"i1551-6776-17-4-340-b8","series-title":"Eur J Cancer","first-page":"2056","article-title":"Evaluation of an oral care protocol intervention in the prevention of chemotherapyinduced oral mucositis in paediatric cancer patients","volume":"37","year":"2001","unstructured":"Cheng\n              KK\n            , MolassiotisA, ChangAM, \n          et al. Evaluation of an oral care protocol intervention in the prevention of chemotherapyinduced oral mucositis in paediatric cancer patients. Eur J Cancer. 2001;37(16):2056\u20132063."},{"key":"i1551-6776-17-4-340-b9","series-title":"Handbook for Reporting Results of Cancer Treatment","first-page":"15","year":"1979","unstructured":"World Health Organization. Handbook for Reporting Results of Cancer Treatment. Geneva, Switzerland: World Health Organization; 1979:15\u201322."},{"key":"i1551-6776-17-4-340-b10","series-title":"Common Terminology Criteria for Adverse Events, version 4.0","year":"2010","unstructured":"Common Terminology Criteria for Adverse Events, version 4.0. U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute. Cancer Therapy Evaluation Program. http:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdf. 2010."},{"issue":"3","key":"i1551-6776-17-4-340-b11","series-title":"Oncol Nurs Forum","first-page":"325","article-title":"Development, testing, and application of the Oral Assessment Guide","volume":"15","year":"1998","unstructured":"Eilers\n              J\n            , BergerAM, PetersonMC.\n          Development, testing, and application of the Oral Assessment Guide. Oncol Nurs Forum. 1998;15(3):325\u2013330."},{"issue":"7, part 2","key":"i1551-6776-17-4-340-b12","series-title":"J Clin Periodontol","first-page":"508","article-title":"Oral complications associated with cancer therapy. An M.D. Anderson Cancer Center Experience","volume":"17","year":"1990","unstructured":"Toth\n              BB\n            , MartinJW, FlemingTJ.\n          Oral complications associated with cancer therapy. An M.D. Anderson Cancer Center Experience. J Clin Periodontol. 1990;17(7, part 2):508\u2013515."},{"issue":"5","key":"i1551-6776-17-4-340-b13","series-title":"Spec Care Dent","first-page":"189","article-title":"Incidence of oral complications and application of a preventive protocol in children with acute leukemia","volume":"18","year":"1998","unstructured":"Levy-Polack\n              MP\n            , SebelliP, PolackNL.\n          Incidence of oral complications and application of a preventive protocol in children with acute leukemia. Spec Care Dent. 1998;18(5):189\u2013193."},{"issue":"2","key":"i1551-6776-17-4-340-b14","series-title":"Pesqui Odontol Bras","first-page":"147","article-title":"Evaluation of an oral preventive protocol in children with acute lymphoblastic leukemia","volume":"17","year":"2003","unstructured":"de Brito Costa\n              EM\n            , FernandesMZ, QuinderLB, \n          et al. Evaluation of an oral preventive protocol in children with acute lymphoblastic leukemia. Pesqui Odontol Bras. 2003;17(2):147\u2013150."},{"key":"i1551-6776-17-4-340-b15","series-title":"Pediatric Lexi-Drugs Online","year":"2011, August 12","unstructured":"Lexi-Comp Online. Pediatric Lexi-Drugs Online. Hudson, Ohio: Lexi-Comp, Inc; 2011, August 12."},{"issue":"6","key":"i1551-6776-17-4-340-b16","series-title":"Cancer Nurs","first-page":"476","article-title":"Palliation of oral mucositis symptoms in pediatric patients treated with cancer chemotherapy","volume":"26","year":"2003","unstructured":"Cheng\n              KK\n            , ChangAM.\n          Palliation of oral mucositis symptoms in pediatric patients treated with cancer chemotherapy. Cancer Nurs. 2003;26(6):476\u2013484."},{"issue":"1","key":"i1551-6776-17-4-340-b17","series-title":"J Pediatr Oncol Nurs","first-page":"41","article-title":"The role of oral glutamine in pediatric bone marrow transplant","volume":"24","year":"2007","unstructured":"Storey\n              B.\n            \n          \n          The role of oral glutamine in pediatric bone marrow transplant. J Pediatr Oncol Nurs. 2007;24(1):41\u201345."},{"issue":"5","key":"i1551-6776-17-4-340-b18","series-title":"Ann Surg","first-page":"772","article-title":"Effect of glutamine on methotrexate efficacy and toxicity","volume":"227","year":"1998","unstructured":"Rubio\n              IT\n            , CaoY, HutchinsLF, \n          et al. Effect of glutamine on methotrexate efficacy and toxicity. Ann Surg. 1998;227(5):772\u2013780."},{"issue":"6S","key":"i1551-6776-17-4-340-b19","series-title":"J Parenter Enteral Nutr","first-page":"83","article-title":"Glutamine facilitates chemotherapy while reducing toxicity","volume":"16","year":"1992","unstructured":"Klimberg\n              SV\n            , NwokediE, HutchinsLF, \n          et al. Glutamine facilitates chemotherapy while reducing toxicity. J Parenter Enteral Nutr. 1992;16(6S):83\u201387."},{"issue":"7","key":"i1551-6776-17-4-340-b20","series-title":"Cancer","first-page":"1433","article-title":"Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy","volume":"83","year":"1998","unstructured":"Anderson\n              PM\n            , SchroederG, SkubitzKM.\n          Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy. Cancer. 1998;83(7):1433\u20131499."},{"issue":"2","key":"i1551-6776-17-4-340-b21","series-title":"J Lab Clin Med","first-page":"223","article-title":"Oral glutamine to prevent chemotherapy induced stomatitis: a pilot study","volume":"127","year":"1996","unstructured":"Skubitz\n              KM\n            , AndersonPM.\n          Oral glutamine to prevent chemotherapy induced stomatitis: a pilot study. J Lab Clin Med. 1996;127(2):223\u2013228."},{"issue":"4","key":"i1551-6776-17-4-340-b22","series-title":"Bone Marrow Transplant","first-page":"339","article-title":"Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation","volume":"22","year":"1998","unstructured":"Anderson\n              PM\n            , RamsayNKC, ShuXO, \n          et al. Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation. Bone Marrow Transplant. 1998;22(4):339\u2013344."},{"issue":"4","key":"i1551-6776-17-4-340-b23","series-title":"J Pediatr","first-page":"758","article-title":"Efficacy of oral sucralfate suspension in prevention and treatment of chemotherapy- induced mucositis","volume":"113","year":"1988","unstructured":"Shenep\n              JL\n            , KalwinskyDK, HutsonPR, \n          et al. Efficacy of oral sucralfate suspension in prevention and treatment of chemotherapy- induced mucositis. J Pediatr. 1988;113(4):758\u2013763."},{"key":"i1551-6776-17-4-340-b24","series-title":"Drug Facts and Comparisons [online]","year":"2012","unstructured":"Caphosol. Drug Facts and Comparisons [online]. 2012. Available from Wolters Kluwer Health, Inc. Accessed August 5, 2012. http:\/\/online.factsandcomparisons.com\/MonoDisp.aspx?monoID=fandc-hcp14030&quick=244598%7c5&search=244598%7c5&isstemmed=True&fromTop=true#firstMatch"},{"issue":"8","key":"i1551-6776-17-4-340-b25","series-title":"Transplant Proc","first-page":"3111","article-title":"Efficiency of supersaturated calcium phosphate mouth rinse treatment in patients receiving high-dose melphalan or BEAM prior to autologous blood stem cell transplantation: a single-center experience","volume":"43","year":"2011","unstructured":"Wasko-Grabowska\n              A\n            , RzepeckiP, OborskaS, \n          et al. Efficiency of supersaturated calcium phosphate mouth rinse treatment in patients receiving high-dose melphalan or BEAM prior to autologous blood stem cell transplantation: a single-center experience. Transplant Proc. 2011;43(8):3111\u20133113."},{"key":"i1551-6776-17-4-340-b26","article-title":"Supersaturated calcium phosphate rinse in preventing oral mucositis in young patients undergoing autologous or donor stem cell transplant","unstructured":"Children's Oncology Group. Supersaturated calcium phosphate rinse in preventing oral mucositis in young patients undergoing autologous or donor stem cell transplant. http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01305200. Updated 9\/12\/2012. Accessed 9\/26\/2012."},{"issue":"10","key":"i1551-6776-17-4-340-b27","series-title":"J Oral Pathol Med","first-page":"486","article-title":"Mucositis prevention by selective elimination of oral flora in irradiated head and neck cancer patients","volume":"19","year":"1990","unstructured":"Spijkervet\n              FKL\n            , van SaeneHKF, van SaeneJJM, \n          et al. Mucositis prevention by selective elimination of oral flora in irradiated head and neck cancer patients. J Oral Pathol Med. 1990;19(10):486\u2013489."},{"key":"i1551-6776-17-4-340-b28","article-title":"Dose escalation study of palifermin in pediatric research participants undergoing allogeneic hematopoietic stem cell transplantation","unstructured":"St. Jude Children's Research Hospital. Dose escalation study of palifermin in pediatric research participants undergoing allogeneic hematopoietic stem cell transplantation. http:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT00701688. Updated 8\/14\/2011. Accessed 8\/15\/2011."},{"issue":"9","key":"i1551-6776-17-4-340-b29","series-title":"Blood","first-page":"3216","article-title":"Phase 1\/2 randomized, placebo-control trial of palifermin to prevent graft-versus-hostdisease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT)","volume":"108","year":"2006","unstructured":"Blazar\n              BR\n            , WeisdorfDJ, DeForT, \n          et al. Phase 1\/2 randomized, placebo-control trial of palifermin to prevent graft-versus-hostdisease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT). Blood. 2006;108(9):3216\u20133222."},{"issue":"6","key":"i1551-6776-17-4-340-b30","series-title":"Ann Intern Med","first-page":"358","article-title":"Singledose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer","volume":"153","year":"2010","unstructured":"Vadhan-Raj\n              S\n            , TrentJ, PatelS, \n          et al. Singledose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer. Ann Intern Med. 2010;153(6):358\u2013367."},{"issue":"25","key":"i1551-6776-17-4-340-b31","series-title":"N Engl J Med","first-page":"2590","article-title":"Palifermin for oral mucositis after intensive therapy for hematologic cancers","volume":"351","year":"2004","unstructured":"Spielberger\n              R\n            , StiffP, BensingerW, \n          et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med. 2004;351(25):2590\u20132598."},{"issue":"5","key":"i1551-6776-17-4-340-b32","series-title":"Cancer","first-page":"820","article-title":"Mucositis Study Section of the Multinational Association of Supportive Care in Cancer, International Society for Oral Oncology. Updated clinical practice guidelines for the prevention and treatment of mucositis","volume":"109","year":"2007","unstructured":"Keefe\n              DM\n            , SchubertMM, EltingLS, \n          et al. Mucositis Study Section of the Multinational Association of Supportive Care in Cancer, International Society for Oral Oncology. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer. 2007;109(5):820\u2013831."},{"issue":"1","key":"i1551-6776-17-4-340-b33","series-title":"Semin Oncol Nurs","first-page":"30","article-title":"Managing pain in mucositis","volume":"20","year":"2004","unstructured":"Epstein\n              JB\n            , SchubertMM.\n          Managing pain in mucositis. Semin Oncol Nurs. 2004;20(1):30\u201337."},{"key":"i1551-6776-17-4-340-b34","series-title":"Cancer Pain Relief with a Guide to Opioid Availability","year":"1996","unstructured":"World Health Organization. Cancer Pain Relief with a Guide to Opioid Availability. 2nd ed. Geneva, Switzerland: World Health Organization; 1996."},{"issue":"1)(suppl","key":"i1551-6776-17-4-340-b35","series-title":"JPEN J Parenter Enteral Nut","first-page":"1SA","article-title":"Board of Directors and the Clinical Guidelines Task Force. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients","volume":"26","year":"2002","unstructured":"A.S.P.E.N.\n          Board of Directors and the Clinical Guidelines Task Force. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nut. 2002;26(1)(suppl):1SA\u2013138SA."}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/17\/4\/article-p340.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/jppt\/article-pdf\/17\/4\/340\/1785833\/1551-6776-17_4_340.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/17\/4\/article-p340.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/17\/4\/article-p340.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:51:19Z","timestamp":1747356679000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/17\/4\/article-p340.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":35,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-17.4.340","relation":{},"ISSN":["1551-6776"],"issn-type":[{"value":"1551-6776","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}